Tech Company Financing Transactions

Tioma Therapeutics Funding Round

Tioma Therapeutics, based in St. Louis, raised $86 million from RiverVest Venture Partners, Novo Ventures and Roche Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4320 Forest Park Ave. 304
St. Louis, MO 63108
USA

Phone

(314) 932-4032

Website

www.tiomatherapeutics.com

Email Address

[email protected]

Overview

Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. Our functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Donovan

        

Chief Operating Officer

James Stutz

        

Chief Scientific Officer

Robert Karr

        

VP - Operations

David Hinds

        

VP - Product Management

Bradley Keller

        

VP - R & D

Pamela Manning

        

Browse more venture capital transactions:

Prev: 8/17/2016: FloSports venture capital transaction
Next: 8/17/2016: Degreed venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary